Clinical Trial: Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC

U.S., March 31 -- ClinicalTrials.gov registry received information related to the study (NCT07500259) titled 'Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC' on March 24.

Brief Summary: The ColoPan study evaluates the scientific validity, reproducibility, and predictive performance of the Personalised Functional Profiling (PFP) platform in colorectal cancer and pancreatic ductal adenocarcinoma patients. It combines genomic sequencing with in vitro functional drug testing using patient-derived spheroids/organoids.

Study Start Date: May 01

Study Type: OBSERVATIONAL

Condition: Colorectal Cancer PDAC - Pancreatic Ductal Adenocarcinoma

Intervention: OTHER: Person...